$170,000–$221,000
USD/year
Serve as a scientific expert in classical homocystinuria (HCU), providing education on Pegtibatinase, Travere's investigational therapy, while supporting Phase 3 clinical trial activities, rapid site enrollment, and expanding disease awareness across specialties that may encounter patients with inborn errors of metabolism. The role involves scientific exchange, external engagement with KOLs and HCPs, and clinical trial support to accelerate patient identification and trial execution.